Related Experiment Videos
Platelet-activating factor concentrations in healthy and septic neonates
N Kültürsay1, M Kantar, M Akisü
1Ege University Faculty of Medicine, Department of Paediatrics, Bornova, Izmir, Turkey.
European Journal of Pediatrics
|September 15, 1999
Summary
Platelet-activating factor (PAF) levels were significantly elevated in preterm infants with Klebsiella pneumonia septicaemia. These findings highlight PAF as a key mediator in neonatal sepsis.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Biochemistry
Background:
- Neonatal sepsis is a serious condition in preterm infants.
- Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and immune responses.
- Gram-negative bacterial infections, such as Klebsiella pneumoniae, are common causes of neonatal sepsis.
Purpose of the Study:
- To investigate and compare Platelet-activating factor (PAF) levels in preterm infants with and without Klebsiella pneumoniae septicaemia.
- To assess the role of PAF as a mediator in neonatal sepsis.
Main Methods:
- Measurement of Platelet-activating factor (PAF) levels in three groups of infants: septic preterm, healthy preterm, and healthy full-term.
- Statistical analysis to compare PAF levels between the groups.
Main Results:
- Platelet-activating factor (PAF) levels were significantly elevated in preterm infants diagnosed with Klebsiella pneumoniae septicaemia compared to healthy preterm and full-term infants (P < 0.01).
- No significant difference in PAF levels was observed between healthy preterm and healthy full-term infants.
Conclusions:
- Elevated Platelet-activating factor (PAF) levels are associated with Gram-negative bacterial infections, specifically Klebsiella pneumoniae septicaemia in preterm neonates.
- Platelet-activating factor (PAF) plays a crucial role as a mediator in the pathogenesis of neonatal sepsis.